World's Best Scientists 2026 revealed!
Allan D. Sniderman

Allan D. Sniderman

D-Index & Metrics

Medicine

D-Index
94
Citations
32397
World Ranking
10489
National Ranking
422

Research.com Recognitions

  • 2009 - Fellow of the Royal Society of Canada Academy of Science

Overview

Allan D. Sniderman is affiliated with McGill University in Canada and has contributed extensively to the field of Medicine, focusing mainly on Endocrinology, Diabetes and Metabolism. Their research also spans Surgery, Cancer Research, Cardiology and Cardiovascular Medicine, and Economics and Econometrics.

Key topics addressed in their body of work include:

  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Lipoproteins and Cardiovascular Health
  • Cancer, Lipids, and Metabolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Lipid metabolism and disorders
  • Nutritional Studies and Diet
  • Acute Ischemic Stroke Management

Frequent co-authors in their publications include:

  • George Thanassoulis
  • Hongyan Ning
  • Norrina B. Allen
  • Venkatesh L. Murthy
  • Donald M. Lloyd-Jones

Their research has been published repeatedly in several notable venues, with multiple articles appearing in:

  • Journal of the American College of Cardiology
  • Circulation
  • JACC Advances
  • Journal of clinical lipidology
  • JAMA Cardiology

Recent publications by Allan D. Sniderman include:

  • Apolipoprotein B vs Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as the Primary Measure of Apolipoprotein B Lipoprotein-Related Risk, 2021, JAMA Cardiology
  • Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels, 2022, International Journal of Molecular Sciences
  • Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?, 2020, Current Cardiology Reports
  • The clinical utility of apoB versus LDL-C/non-HDL-C, 2020, Clinica Chimica Acta
  • Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE), 2022, Journal of Stroke

They were recognized as a Fellow of the Royal Society of Canada in 2009 within the Academy of Science.

Best Publications

  • Impact of left ventricular hypertrophy on survival in end-stage renal disease.

    Jonathan S. Silberberg;Paul E. Barre;Sarah S. Prichard;Allan D. Sniderman

  • Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study

    Matthew J McQueen;Steven Hawken;Xingyu Wang;Stephanie Ounpuu

  • 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations

    Jacques Genest;Ruth McPherson;Jiri Frohlich;Todd Anderson

  • Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

    Allan Sniderman;Stanley Shapiro;Derek Marpole;Bernard Skinner

  • The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

    Lucien Campeau;Marc Enjalbert;Jacques Lespérance;Martial G. Bourassa

  • A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk

    Allan D. Sniderman;Ken Williams;John H. Contois;Howard M. Monroe

  • Application of New Cholesterol Guidelines to a Population-Based Sample

    Michael J. Pencina;Ann Marie Navar-Boggan;Ralph B. D'Agostino;Ken Williams

  • Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

    AD Sniderman;CD Furberg;A Keech;JE Roeters van Lennep

  • Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects

    May Faraj;Peter J. Havel;Steve Phélis;David Blank

  • Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.

    P J Barter;C M Ballantyne;R Carmena;M Castro Cabezas

  • Hypertriglyceridemic HyperapoB: The Unappreciated Atherogenic Dyslipoproteinemia in Type 2 Diabetes Mellitus

    Allan D. Sniderman;Thea Scantlebury;Katherine Cianflone

  • Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis

    Allan D Sniderman;Raj Bhopal;Dorairaj Prabhakaran;Nizal Sarrafzadegan

  • Hyperlipidemia in Early Adulthood Increases Long-Term Risk of Coronary Heart Disease

    Ann Marie Navar-Boggan;Eric D. Peterson;Ralph B. D’Agostino;Benjamin Neely

  • Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.

    Michael H. Davidson;Christie M. Ballantyne;Terry A. Jacobson;Vera A. Bittner

  • The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.

    Göran Walldius;Ingmar Jungner;Are H Aastveit;Ingar Holme

  • Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.

    Allan D. Sniderman;Christina Wolfson;Babie Teng;Frank A. Franklin

  • Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge.

    K M Cianflone;Z Yasruel;M A Rodriguez;D Vas

  • Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.

    Babie Teng;A. D. Sniderman;A. K. Soutar;G. R. Thompson

  • Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review.

    Allan D. Sniderman;George Thanassoulis;Tamara Glavinovic;Ann Marie Navar;Ann Marie Navar

  • Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

    A. Sniderman;C.D. Furberg;A. Keech;J.E. Roeters van Lennep

Frequent Co-Authors

Katherine Cianflone
Katherine Cianflone Université Laval
Michael J. Pencina
Michael J. Pencina Duke University
Kenneth R. Williams
Kenneth R. Williams Yale University
Ralph B. D'Agostino
Ralph B. D'Agostino Wake Forest University
Curt D. Furberg
Curt D. Furberg Wake Forest University
Donald M. Lloyd-Jones
Donald M. Lloyd-Jones Northwestern University
Seth S. Martin
Seth S. Martin Johns Hopkins University
Keith N. Frayn
Keith N. Frayn University of Oxford
Michael V. Holmes
Michael V. Holmes University of Oxford
Matthew J. McQueen
Matthew J. McQueen McMaster University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always mean you need to pursue the traditional MD route in the USA. There are a variety of flexible, valuable online degree programs that can lead to rewarding healthcare careers. For example, those interested in mental health can explore online msn pmhnp programs, which train you to become a Psychiatric Mental Health Nurse Practitioner.

If you have an interest in healthcare leadership, options like the online master of health administration provide pathways into management roles. These programs emphasize skills in policy, operations, and leadership across medical institutions.

Cost is often a concern for students, but there are online mha programs affordable, helping you advance your career without a large financial burden. For those already holding a BSN, specialized programs like the best online bsn to dnp programs can help you reach top clinical and leadership positions.

These diverse online degrees offer flexible, accessible alternatives to traditional medical study and open a range of dynamic healthcare career pathways.

Best Scientists Citing Allan D. Sniderman

Trending Scientists